MENU
+Compare
CLGN
Stock ticker: NASDAQ
AS OF
Oct 8, 04:58 PM (EDT)
Price
$2.33
Change
+$0.13 (+5.91%)
Capitalization
29.12M

CLGN CollPlant Biotechnologies Ltd Forecast, Technical & Fundamental Analysis

CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics... Show more

Industry: #Biotechnology
CLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CLGN with price predictions
Oct 07, 2025

CLGN in +23.83% Uptrend, advancing for three consecutive days on September 26, 2025

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where CLGN advanced for three days, in of 234 cases, the price rose further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Bearish Trend Analysis

The 10-day RSI Indicator for CLGN moved out of overbought territory on September 30, 2025. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 25 similar instances where the indicator moved out of overbought territory. In of the 25 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on October 01, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on CLGN as a result. In of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for CLGN turned negative on October 01, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 42 similar instances when the indicator turned negative. In of the 42 cases the stock turned lower in the days that followed. This puts the odds of success at .

CLGN moved below its 50-day moving average on October 01, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CLGN declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CLGN broke above its upper Bollinger Band on September 25, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CLGN’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.329) is normal, around the industry mean (23.421). P/E Ratio (0.000) is within average values for comparable stocks, (54.441). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.237). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (11.013) is also within normal values, averaging (342.085).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CLGN’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

View a ticker or compare two or three
CLGN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CLGN is expected to report earnings to fall 32.61% to 15 cents per share on November 26

CollPlant Biotechnologies Ltd CLGN Stock Earnings Reports
Q3'25
Est.
$0.16
Q2'25
Beat
by $0.37
Q1'25
Beat
by $0.47
Q4'24
Missed
by $0.06
Q3'24
Missed
by $0.09
The last earnings report on August 20 showed earnings per share of 23 cents, beating the estimate of -14 cents. With 60.30K shares outstanding, the current market capitalization sits at 29.12M.
A.I. Advisor
published General Information

General Information

a developer of medical devices

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
4 Oppenheimer Street
Phone
+972 732325600
Employees
73
Web
https://www.collplant.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TOPS5.850.16
+2.81%
TOP Ships
PWR421.51-6.29
-1.47%
Quanta Services
ABG243.20-4.31
-1.74%
Asbury Automotive Group
TRIN14.74-0.32
-2.09%
Trinity Capital
JILL15.06-0.67
-4.26%
JJill

CLGN and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CLGN has been loosely correlated with SPRO. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if CLGN jumps, then SPRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CLGN
1D Price
Change %
CLGN100%
-7.56%
SPRO - CLGN
38%
Loosely correlated
+3.35%
CMVLF - CLGN
37%
Loosely correlated
N/A
CLLS - CLGN
33%
Poorly correlated
+8.22%
ALZN - CLGN
28%
Poorly correlated
-2.73%
NEVPF - CLGN
26%
Poorly correlated
N/A
More